drugset / Trial / NCT02303314

Efficacy of Oral Trigonella Foenum-graecum Seed Extract Vs Placebo in Treatment of None Alcoholic Fatty Liver Disease

NCT02303314 ↗

Phase 2/3 Completed 35 enrolled Shiraz University of Medical Sciences
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study design to examine performance of trigonella foenum-graecum (TFG) in treatment of non-alcoholic fatty liver disease. Base on inclusion and exclusion criteria, 50 patients select and then randomize into intervention and control groups. Two group use capsules which contain TFG or placebo, respectively.

Timeline

Start
2014-11
Primary completion
2017-08
Completion
2017-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Trigonella Foenum-graecum Seed Extract Unknown 1 g Oral

Indications